Acadian Asset Management LLC Has $2.97 Million Holdings in Mettler-Toledo International, Inc. $MTD

Acadian Asset Management LLC lifted its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 84.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,513 shares of the medical instruments supplier’s stock after acquiring an additional 1,154 shares during the period. Acadian Asset Management LLC’s holdings in Mettler-Toledo International were worth $2,965,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the company. GAMMA Investing LLC grew its holdings in shares of Mettler-Toledo International by 131,246.3% during the 1st quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier’s stock valued at $456,018,000 after purchasing an additional 385,864 shares during the last quarter. Alliancebernstein L.P. grew its stake in shares of Mettler-Toledo International by 21.6% during the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock worth $837,653,000 after buying an additional 126,147 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Mettler-Toledo International by 42.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 305,722 shares of the medical instruments supplier’s stock worth $361,030,000 after buying an additional 90,395 shares during the last quarter. Nuveen LLC acquired a new position in shares of Mettler-Toledo International during the first quarter worth $71,897,000. Finally, Jones Financial Companies Lllp increased its holdings in shares of Mettler-Toledo International by 27,938.9% during the first quarter. Jones Financial Companies Lllp now owns 49,068 shares of the medical instruments supplier’s stock worth $57,945,000 after buying an additional 48,893 shares in the last quarter. 95.07% of the stock is owned by institutional investors.

Analyst Ratings Changes

MTD has been the subject of several recent research reports. Barclays assumed coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an “overweight” rating and a $1,325.00 price objective for the company. Evercore ISI dropped their price target on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating on the stock in a research note on Monday, August 4th. Citigroup raised their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research note on Thursday, August 21st. Robert W. Baird raised their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a research note on Monday, August 4th. Finally, Bank of America upped their target price on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a “neutral” rating in a research report on Thursday, June 26th. Five analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $1,311.11.

Insiders Place Their Bets

In related news, Director Thomas P. Salice sold 1,062 shares of the company’s stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the completion of the transaction, the director owned 283 shares of the company’s stock, valued at approximately $368,154.70. This represents a 78.96% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Gerry Keller sold 165 shares of the business’s stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the sale, the insider owned 94 shares of the company’s stock, valued at approximately $123,012.16. This trade represents a 63.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 1,827 shares of company stock valued at $2,371,208. 0.77% of the stock is currently owned by corporate insiders.

Mettler-Toledo International Trading Up 0.2%

NYSE:MTD opened at $1,262.22 on Tuesday. The business’s 50-day moving average is $1,260.42 and its 200 day moving average is $1,184.76. Mettler-Toledo International, Inc. has a 12 month low of $946.69 and a 12 month high of $1,521.01. The company has a market capitalization of $26.00 billion, a P/E ratio of 31.96, a P/E/G ratio of 3.78 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping the consensus estimate of $9.58 by $0.51. The company had revenue of $983.22 million for the quarter, compared to analysts’ expectations of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same period in the previous year, the firm posted $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, research analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.